Key result
Perioperative withholding of antithrombotics in cutaneous surgery may be associated with serious adverse vascular events, whereas continuing them does not significantly increase bleeding.
Why the study?
Does perioperative continuation of antithrombotic drugs prevent serious adverse vascular events without significantly increasing bleeding complications in patients undergoing cutaneous surgery?
Population
Patients undergoing cutaneous surgery who are on antithrombotic medications
Comparison
Perioperative continuation of antithrombotic drugs vs Preoperative discontinuation of antithrombotic…
Design
Review
Authors
Loading...
May support continuing antithrombotics in cutaneous surgery; leaves open confirmation by randomized trials.
Does perioperative continuation of antithrombotic drugs prevent serious adverse vascular events without significantly increasing bleeding complications in patients undergoing cutaneous surgery?
Cutaneous surgeons should strongly consider continuing patients' antithrombotic drugs perioperatively to avoid serious adverse vascular events, as bleeding risk is not significantly increased.
Alam et al. (2002) conducted a review in Patients on antithrombotic therapy undergoing cutaneous surgery (n=2). Preoperative discontinuation of antithrombotics vs. Continuation of antithrombotics was evaluated on Serious adverse vascular events and bleeding complications. Perioperative withholding of antithrombotics in cutaneous surgery may be associated with serious adverse vascular events, whereas continuing them does not significantly increase bleeding.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: